Standout Papers

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck... 2009 2026 2014 2020 1.2k
  1. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial (2011)
    Christopher M. Nutting, James P. Morden et al. The Lancet Oncology
  2. Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer (2009)
    David Cunningham, Ian Chau et al. Journal of Clinical Oncology

Immediate Impact

8 from Science/Nature 64 standout
Sub-graph 1 of 21

Citing Papers

Pancreatic cancer
2025 Standout
Radiotherapy toxicities: mechanisms, management, and future directions
2025 Standout
5 intermediate papers

Works of F. Adab being referenced

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial
2011 Standout
Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer
2009 Standout

Author Peers

Author Last Decade Papers Cites
F. Adab 833 973 911 873 14 2.1k
Sing-Fai Leung 730 1140 634 782 23 2.1k
Antoine Lusinchi 1184 1082 845 730 33 2.2k
James P. Morden 615 1060 1064 822 48 2.5k
Lisbeth Juhler Andersen 1227 1206 724 934 48 2.3k
Peter M.L. Teo 1156 1831 1093 950 34 2.8k
Peter H. Blitzer 1190 389 1163 881 42 2.6k
Sunil Gulavita 457 391 1013 755 20 2.8k
Daniëlle Van den Weyngaert 838 1203 720 654 26 1.8k
William J. Spanos 1025 996 799 978 59 2.8k
R. Le Fur 552 839 647 477 16 1.5k

All Works

Loading papers...

Rankless by CCL
2026